Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells

Hypertension

Volumn 30, Issue 4, 1997, Pages 873-879

  Natarajan, Rama ^a   Rosdahl, Jullia ^a   Gonzales, Noe ^a   Bai, Wei ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

12 lipoxygenase; Interleukin; Muscle, smooth

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 8; MESSENGER RNA;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENZYME REGULATION; HYPERTENSION; IMMUNOREGULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR SMOOTH MUSCLE;

EID: 0030856747     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.4.873     Document Type: Article

References (37)

1. Ross R. The pathogenesis of atherosclerosis. Nature. 1993;37: 801-809.
2. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation. 1995;91: 2488-2496.
3. Libby P, Stephen J, Warner C. Interieukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest. 1988;81:487-498.
4. Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med. 1992;116:1292-1300.
5. Hansson GK, Holm J, Jonsson L, Detection of activated T-lymphocytes in the human atherosclerotic plaque. Am J Pathol. 1989;135:169-175.
6. Libby P, Hansson GK. Biology of disease: involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 1991;64:5-15.
7. DiMarzo V. Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions. Prost Leuk Essent Fatty Acids. 1995;53:239-254.
8. Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J. 1989;259:315-324.
9. Izumi T, Hoshiko S, Radmark O, Samuelsson S. Cloning of the cDNA for human 12-lipoxygenase. Proc Natl Acad Sci U S A. 1990;87:7477-7481.
10. Yamamoto S. Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta. 1992;1128:117-131.
11. Funk CD. Molecular biology in the eicosanoid field. In: Cohn W, Moldave K, eds. Progress in Nucleic Acid Research and Molecular Biology. Orlando, Fla: Academic Press, Inc; 1993;45:67-98.
12. Sisal E. The molecular biology of mammalian arachidonic acid metabolism. Am J Physiol. 1991;260:L13-L28.
13. Yoshimoto T, Suzuki H, Yamamoto S, Takai T, Yokoyama C, Tanabe T. Cloning and sequence analysis of the cDNA for arachidonate 12-lipoxygenase of porcine leukocytes. Proc Natl Acad Sci U S A. 1990;87-2142-2146.
14. Natarajan R, Gu JL, Rossi J, Gonzales N, Lanting L, Xu L, Nadler J. Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1993;90:4947-4951.
15. Gu JL, Natarajan R, Ben-Ezra J, Valente G, Scott S, Yoshimoto T, Yamamoto S, Rossi JJ, Nadler J. Evidence that a leukocyte-type of 12-lipoxygenase is expressed and regulated by angiotensin II in human adrenal glomerulosa cells. Endocrinology. 1994;134:70-77.
16. Kim JA, Gu JL, Natarajan R, Esteban J, Berliner JA, Nadler J. A leukocyte-type of 12-lipoxygenase is expressed in human vascular and mononuclear cells: evidence for upregulation by angiotensin II. Arterioscler Thromb Vasc Biol. 1995;15:942-948.
17. Parthasarathy S, Wieland E, Steinberg D. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci U S A 1989;86:1046-1050.
18. Yla-Hertualla S, Rosenfeld M, Parthasarathy S, Glass C, Sigal E, Witztum J, Steinberg D. Colocalization of 15-LO mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci U S A. 1990;87:6959-6963.
19. Folcik VA, Nivar-Aristy RA, Krajewski LP, Cathcart MA. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J Clin Invest. 1995;96:504-510.
20. Antonipillai I, Horton R, Natarajan R, Nadler J. A 12-lipoxygenase product of arachidonate metabolism is involved in angiotensin action on renin release. Endocrinology. 1989;125:2028-2034.
21. Stern N, Golub M, Nozawa K, Berger M, Knoll E, Yanagawa N, Natarajan R, Tuck ML, Nadler J. Selective inhibition of angiotensin II-mediated vasoconstriction by lipoxygenase blockade. Am J Physiol. 1989;257:H434-H443.
22. Nozawa K, Tuck ML, Golub M, Eggena P, Nadler JL, Stern N. Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats. Am J Physiol. 1990;259:H1774-H1780.
23. Stern N, Eldad KS, Knoll E. Platelet lipoxygenase in spontaneously hypertensive rats. Hypertension. 1996;27:1149-1152.
24. Nakao J, Ooyama T, Ito H, Chang WC, Murota S. Comparative effects of lipoxygenase products of arachidonic acid on rat aortic smooth muscle cell migration. Atherosclerosis. 1982;44:339-342.
25. Natarajan R, Gonzales N, Lanting L, Nadler J. Role of the lipoxygenase pathway in angiotensin Il-induced vascular smooth muscle cell hypertrophy. Hypertension. 1994;23(suppl I):I-142-I-147.
26. Natarajan R, Bai W, Rangarajan V, Gonzales N, Gu JL, Lanting L, Nadler JL. Platelet-derived growth factor BB-mediated regulation of 12-lipoxygenase in porcine aortic smooth muscle cells. J Cell Physiol. 1996;169:391-400.
27. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science. 1989;243:393-396.
28. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis: a special case of atherosclerosis progression. Circulation. 1992;86(suppl III):III-47-III-52.
29. Iademarco MF, Barks JL, Dean DC. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-α in cultured endothelial cells. J Clin Invest. 1995;95:264-271.
30. Li H, Cybulsky MI, Gimbrone MA, Libby P. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol. 1993;143: 1551-1559.
31. Herbert CA, Baker JB. Interleukin-8: a review. Cancer Invest. 1993; 11:743-750.
32. Yue T, Wang X, Sung C, Olsen B, Mckenna PJ, Gu J, Feuerstein GZ. Interleukin-8: a mitogen and chemoattractant for vascular smooth muscle cells. Circ Res. 1994;75:1-7.
33. Apostolopoulos J, Davenport P, Tipping PJ. Interleukin-8 production by macrophages from atheromatous plaques. Arterioscler Thromb Vasc Biol 1996;16:1007-1012.
34. Conrad DJ, Kuhn H, Mulkins M, Highland E, Sigal E. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci U S A. 1992;89:217-222.
35. Nasser GM, Morrow JD, Robert LJ II, Lakkis FJ, Badr KF. Induction of 15-lipoxygenase by IL-13 in human blood monocytes. J Biot Chem. 1994;269:27631-27634.
36. Natarajan R, Stern N, Nadler J. Arachidonic acid metabolites on renin and vascular smooth musele cell growth. In: Sowers JR, ed. Contemporary Endocrinology: Endocrinology of the Vasculature. Totowa, NJ: Humana Press; 1996:373-387.
37. Gu JL, Veerapanane D, Rossi JJ, Natarajan R, Thomas L, Nadler J, Ribozyme-mediated inhibition of expression of leukocyte-type 12-lipoxygenase in porcine aortic vascular smooth muscle cells. Circ Res. 1995;77:14-20.